A recent study by researchers at Dublin City University and the National Cancer Institute in the USA has uncovered new clues about the biology of the predominan...
Scientists from the Apoptosis Research Centre at NUI Galway have found that targeting the IRE1 stress response pathway may improve the response to chemotherapy and reduce relapse for patients with triple negative breast cancer. These first in world r...
OncoMark Ltd, an Irish diagnostics company focused on the development of novel panels of cancer biomarkers to aid treatment decisions for cancer patients, today...
Elaine Sullivan, co-founder and CEO of Carrick Therapeutics, (www.carricktherapeutics.com), an early-stage life-sciences company which has raised $95 million in...
University College Dublin (UCD), the National Children’s Research Centre (NCRC), and the Children’s Medical and Research Foundation (CMRF) Crumlin today announced the appointment of Jonathan Bond to the newly established Brendan McGonnell UCD Profess...
OncoMark, a University College Dublin (UCD) spin-out company, has been selected for €2.7 million in funding over 2-years, through the latest round of Horizon 20...